市場調査レポート
商品コード
1558381

放射線腫瘍学の市場規模および予測、世界および地域別シェア、動向、成長機会分析レポート:タイプ別、用途別、地域別

Radiation Oncology Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 170 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.38円
放射線腫瘍学の市場規模および予測、世界および地域別シェア、動向、成長機会分析レポート:タイプ別、用途別、地域別
出版日: 2024年08月30日
発行: The Insight Partners
ページ情報: 英文 170 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の放射線腫瘍学市場は2023年の89億2,444万米ドルから成長し、2031年には236億2,056万米ドルに達すると予測されており、2023年から2031年にかけて13.0%のCAGRを記録する見込みです。放射線腫瘍学市場の成長は、がんの有病率の増加と放射線腫瘍学の市場開拓を支援するイニシアチブの急増に起因しています。放射線腫瘍学市場のプレーヤーによる戦略的イニシアチブは、市場成長の機会を提供する可能性が高いです。放射線腫瘍学市場レポートは、市場を牽引する主な要因を強調し、著名企業の市場開拓を紹介しています。

放射線療法または放射線治療は、放射線(通常は高出力X線)を使用してがん細胞を死滅させる一般的ながん治療です。放射線療法は単独で用いられることもあれば、手術や化学療法など他の治療と並行して用いられることもあります。放射線腫瘍学医は放射線療法を専門とするヘルスケアプロバイダーです。

2023年の世界の放射線腫瘍学市場では、北米が大きなシェアを占めています。北米の放射線腫瘍学市場は、米国、カナダ、メキシコに区分されます。米国では、すべてのがん患者に対して放射線療法が広く行われており、放射線腫瘍学医のニーズは増加の一途をたどっています。医療インフラが発達しているため、放射線腫瘍学医の数も増加の一途をたどっています。とはいえ、米国臨床腫瘍学会(American Society of Clinical Oncology)によれば、世界のがん患者の約3分の2は治療の一環として放射線療法を受けていると推定されています。2022年には、米国で年間100万人以上のがん患者が放射線療法を受けると予測されています。政府やヘルスケア当局は、放射線治療の導入を促進するためにいくつかのイニシアチブをとっています。2020年6月、米国放射線腫瘍学会(ASTRO)は、非転移性子宮頸がんに対する放射線療法に関する新しい臨床ガイドラインを発表しました。新ガイドラインは、放射線治療を実施するための手順やプロセスを正確に実施することに重点を置いています。カナダ放射線腫瘍学会(CARO)は、放射線腫瘍学に関する具体的なガイドラインを制定しています。Japanese Journal of Clinical Oncologyに掲載された研究によると、オンタリオ州では年間35,000人近くの患者が放射線療法を受けており、これは同州のがん患者の約39%を占める。カナダの人口ベースの単一支払いがんシステムは、アクセス、診断の質、治療結果、サポートを強化するために絶えず変化しています。この制度は放射線治療もうまく位置づけており、人々がこの治療を十分に受けられるようにしています。とはいえ、この治療へのアクセスには注意深い監視が必要です。カナダは、人口の高齢化と技術の進歩に伴い、今後も技術革新、調査、放射線腫瘍学の実践を変えていく予定です。がん罹患率の上昇、政府の取り組み、技術の向上は、メキシコの放射線腫瘍学市場の成長を促すいくつかの要因です。同国では特に肺がん、前立腺がん、乳がんの罹患率が高く、効果的な治療のために放射線治療の需要が高まっています。メキシコ政府は、海外からの投資や国際的なプレイヤーの誘致に力を入れています。例えば、2018年、Elektaは、放射線治療システムを納入するためにメキシコ政府から入札を受けた。このような協力関係は、予測期間中にメキシコ放射線腫瘍学市場を後押しすると予測されています。

放射線腫瘍学における戦略的取り組みが今後の市場機会をもたらす

放射線腫瘍学は、がん治療において非常に大きな可能性を秘めています。さらに、製品開発、技術革新、製品発売、製品承認、合併、買収、提携など、市場プレーヤーによる放射線治療の絶え間ない進化が市場成長に寄与すると期待されています。同市場で最近行われた戦略的イニシアチブの一部を紹介します。

2024年5月、Elekta社は、最新のリニアック(リニアック)であるEvoを発売しました。Evoは、新しい高精細AI強化イメージングを搭載したCTリニアックで、標準的な画像誘導放射線治療だけでなく、オフラインおよびオンライン適応放射線治療を改善することができます。

2024年5月、アイコングループはサイバーナイフ・オーストラリア社と提携し、「サイバーナイフ」システムを使用した放射線腫瘍学治療を提供する最大6つの放射線腫瘍学クリニックを新設(合弁事業案)。

2024年5月、GEヘルスケアは、革新的なハードウェアおよびソフトウェアソリューションを搭載した新しい放射線治療用CTソリューションであるレボリューションRTを発売。

2024年4月、アキュレイ・インコーポレイテッドはESTRO 2024において、がん治療体験を向上させるために設計されたハードウェアとソフトウェアの進歩を展示しました。最新世代のサイバーナイフとRadixactプラットフォームは、放射線治療の治癒力を拡大し、今年の会議の焦点であるケアギャップを埋めるために必要な技術を医療チームに提供します。

2023年10月、CIVCO RadiotherapyとQfixは新ブランドCQ Medicalを立ち上げました。同社は、臨床医や技術パートナーとの現場での深い関わりとともに、がん治療と患者の転帰の改善に重点を置く。

2023年9月、MVision AIは、効果的な放射線治療の輪郭形成のための初の包括的なGuideline-Based Segmentation(GBS)ソリューションを発表しました。Guideは、臨床チームがAIが生成した構造を正確に評価することを容易にし、輪郭形成のスキルを磨くことを可能にします。Verifyは、輪郭の視覚的・体積的比較を可能にし、クリニックが類似点や相違点を観察することを容易にします。Guide VerifyとContour+を組み合わせて導入することで、放射線治療の輪郭形成におけるあらゆる臨床ニーズが網羅されます。

したがって、放射線腫瘍学市場で事業を展開する市場プレイヤーの間で戦略的イニシアティブが急増しており、これが市場の成長を増幅し、放射線腫瘍学市場に十分な機会を創出すると期待されています。

放射線腫瘍学市場競合情勢と主な発展

Varian Medical Systems Inc、Elekta AB、Accuracy Incorporated、IBA Worldwide(Ion Beam Applications SA)、Becton Dickinson &Co、Perspective Therapeutics Inc、Nordion、Mevion Medical Systems、NTP Radioisotopes、Mallinckrodt Plc.などが放射線腫瘍学市場で事業を展開する主要企業です。

米国食品医薬品局、米国疾病管理予防センター(CDC)、米国放射線腫瘍学会などは、放射線腫瘍学市場レポート作成時に参照した一次情報および二次情報の一つです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の作成
    • データの三角測量
    • 国レベルのデータ

第4章 放射線腫瘍学市場の情勢

  • PEST分析

第5章 放射線腫瘍学市場-主要市場力学

  • 放射線腫瘍学市場- 主な市場力学
  • 市場促進要因
    • がんの有病率の増加
    • 放射線腫瘍学の発展を支援する取り組み
  • 市場抑制要因
    • 放射線治療機器の高コスト
  • 市場機会
    • 放射線腫瘍学における戦略的イニシアティブ
  • 今後の動向
    • 放射線腫瘍学の技術進歩
  • 促進要因と抑制要因の影響

第6章 放射線腫瘍学市場:世界市場分析

  • 放射線腫瘍学市場の収益、2021-2031年

第7章 放射線腫瘍学市場分析:タイプ別

  • 外部ビーム放射線療法
  • 内部ビーム放射線療法

第8章 放射線腫瘍学市場分析:用途別

  • 乳がん
  • 前立腺がん
  • 肺がん
  • 頭頸部がん
  • 子宮頸がん
  • その他

第9章 放射線腫瘍学市場:地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • その他中東とアフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第10章 放射線腫瘍学市場:業界情勢

  • 放射線腫瘍学市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略
    • 成長戦略

第11章 企業プロファイル

  • Varian Medical Systems Inc
  • Elekta AB
  • Accuray Incorporated
  • IBA Worldwide(Ion Beam Applications SA)
  • Becton Dickinson and Co
  • Perspective Therapeutics Inc
  • Nordion
  • Mevion Medical Systems
  • NTP RADIOISOTOPES
  • Mallinckrodt Plc
  • Provision Healthcare
  • Panacea Medical Technologies Pvt. Ltd
  • Curium

第12章 付録

図表

List Of Tables

  • Table 1. Radiation Oncology Market Segmentation
  • Table 2. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 3. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 4. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 5. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 6. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 7. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 8. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 9. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 11. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 12. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 13. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 14. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 15. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 16. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 17. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 18. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 19. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 20. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 21. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 22. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 23. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 24. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 25. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 26. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 27. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 28. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 29. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 30. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 31. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 32. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 33. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 34. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 35. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 36. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 37. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 38. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 39. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 40. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 41. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 42. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 43. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 44. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 45. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 46. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 47. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 48. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 49. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 50. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 51. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 52. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 53. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 54. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 55. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 56. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 57. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 58. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 59. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 60. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 61. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 62. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 63. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 64. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 65. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 66. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 67. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 68. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 69. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 70. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 71. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 72. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 73. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 74. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 75. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 76. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 77. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 78. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 79. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 80. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 81. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 82. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 83. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 84. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 85. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 86. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 87. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 88. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 89. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 90. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 91. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 92. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 93. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 94. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 95. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 96. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 97. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 98. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 99. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 100. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 101. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 102. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 103. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 104. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 105. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 106. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 107. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 108. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 109. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 110. Recent Organic Growth Strategies in Radiation Oncology Market
  • Table 111. Recent Inorganic Growth Strategies in the Radiation Oncology Market
  • Table 112. Glossary of Terms, Radiation Oncology Market

List Of Figures

  • Figure 1. Radiation Oncology Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Statistics at Glance, Global, 2022
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
  • Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
  • Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
  • Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 17. North America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 18. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 19. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 20. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 21. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 22. Europe: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 23. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 24. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 25. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 26. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 27. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 28. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 29. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. Asia Pacific: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 31. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 35. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 37. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. Middle East and Africa: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 39. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 40. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 42. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. South and Central America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 45. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 46. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 47. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 48. Growth Strategies in Radiation Oncology Market
目次
Product Code: TIPRE00004195

According to our new research study on "Radiation Oncology Market Forecast to 2031 -Global Analysis - by Type, Application, and Geography," the market is anticipated to grow from US$ 8,924.44 million in 2023 and is projected to reach US$ 23,620.56 million by 2031; it is expected to register a CAGR of 13.0% during 2023-2031. The radiation oncology market growth is attributed to the increasing prevalence of cancer and surging initiatives to support developments in radiation oncology. Strategic initiatives by radiation oncology market players are likely to offer opportunities for market growth. The radiation oncology market report emphasizes the key factors driving the market and showcases the developments of prominent players.

Radiation therapy or radiotherapy is a common cancer treatment that uses radiation (usually high-powered X-rays) to kill cancer cells. Radiation therapy may be used independently or alongside other treatments, like surgery or chemotherapy. Radiation oncologists are healthcare providers who specialize in radiation therapy.

North America accounted for a major share of the global radiation oncology market in 2023. The North America radiation oncology market is segmented into the US, Canada, and Mexico. Radiation therapy is widely available for all cancer patients in the US, and the need for radiation oncologists is continuously on the rise. The number of these professionals also increases continuously owing to the developed healthcare infrastructure. Nevertheless, the American Society of Clinical Oncology approximately two-thirds of cancer patients globally are estimated to receive radiation therapy as a part of their treatment. In 2022, over 1 million cancer patients in the US are projected to undergo radiation therapy annually. The government and healthcare authorities are taking several initiatives to encourage the adoption of radiotherapy. In June 2020, the American Society for Radiation Oncology (ASTRO) introduced new clinical guidelines regarding radiotherapy for nonmetastatic cervical cancer. The new guidelines focus on precisely implementing steps and processes to conduct radiation therapy. The Canadian Association of Radiation Oncology (CARO) has established specific guidelines about radiation oncology. A study published in the Japanese Journal of Clinical Oncology reports that nearly 35,000 patients in Ontario receive radiation therapy annually, accounting for ~39% of cancer patients in the province. Canada's population-based, single-payer cancer system constantly changes to enhance access, diagnosis quality, treatment outcomes, and support. It has also positioned radiotherapy well, ensuring that people have sufficient access to this treatment. Nonetheless, access to the treatment needs close monitoring. Canada plans to continue to innovate, conduct research, and change the practice of radiation oncology as its population ages and technology advances. Rising cancer incidence, government initiatives, and technology improvements are a few factors driving growth of the radiation oncology market in Mexico. The country specifically records high incidences of lung, prostate, and breast cancer, resulting in an elevated demand for radiation therapy for effective treatment. The government of Mexico focuses on attracting significant foreign investments and international players. For instance, in 2018, Elekta received a tender from the government of Mexico to deliver radiation therapy systems. Such collaborations are estimated to boost the Mexico radiation oncology market during the forecast period.

Strategic Initiatives in Radiation Oncology to Provide Market Opportunities in Future

Radiation oncology holds tremendous potential in cancer treatment. Additionally, constant evolution in radiotherapy by the market players in terms of product development, innovation, product launch, product approval, merger, acquisition and partnerships, and others is expected to contribute the market growth. Some of the recent strategic initiatives taken place in the market are

In May 2024, Elekta launched its latest linear accelerator (linac), Evo, a CT-Linac with new high-definition AI enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments.

In May 2024, The Icon Group collaborated with Cyberknife Australia Pty Ltd to establish up to 6 new radiation oncology clinics (proposed joint venture), which will provide radiation oncology treatments using the 'Cyberknife' system.

In May 2024, GE HealthCare launched Revolution RT, a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients.

In April 2024, Accuray Incorporated showcased advancement in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife and Radixact platforms provide medical care teams with the technology necessary for expanding the curative power of radiation therapy and delivering on the focus of this year's congress, bridging the care gap.

In October 2023, CIVCO Radiotherapy and Qfix launched a new brand CQ Medical. The company focuses on the improvement of cancer care and patient outcome along with deep engagement in the field with clinicians and technology partners.

In September 2023, MVision AI launched the first comprehensive Guideline-Based Segmentation (GBS) solution for effective radiation therapy contouring. Guide facilitates clinical teams to accurately evaluate AI-generated structures, thus enabling them to refine their contouring skills. Verify allows visual and volumetric comparison of contours, facilitating clinics to observe similarities and differences. The combined implementation of Guide Verify and Contour+ encompasses all clinical needs in radiotherapy contouring.

Therefore, surging strategic initiatives among market players operating in radiation oncology market which are expected to amplify the market growth and create ample opportunities for the radiation oncology market.

Radiation Oncology Market: Competitive Landscape and Key Developments

Varian Medical Systems Inc, Elekta AB, Accuracy Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson & Co, Perspective Therapeutics Inc, Nordion, Mevion Medical Systems, NTP Radioisotopes, and Mallinckrodt Plc. are among the key companies operating in the radiation oncology market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and American Society for Radiation Oncology are among the primary and secondary sources referred to while preparing the radiation oncology market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Radiation Oncology Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Radiation Oncology Market - Key Market Dynamics

  • 5.1 Radiation Oncology Market - Key Market Dynamics
  • 5.2 Market Drivers:
    • 5.2.1 Increasing Prevalence of Cancer
    • 5.2.2 Initiatives to Support Developments in Radiation Oncology
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Radiotherapy Equipment
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives in Radiation Oncology
  • 5.5 Future Trends
    • 5.5.1 Technological Advancement in Radiation Oncology
  • 5.6 Impact of Drivers and Restraints:

6. Radiation Oncology Market - Global Market Analysis

  • 6.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031

7. Radiation Oncology Market Analysis - by Types

  • 7.1 External Beam Radiation Therapy
    • 7.1.1 Overview
    • 7.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Internal Beam Radiation Therapy
    • 7.2.1 Overview
    • 7.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

8. Radiation Oncology Market Analysis - by Application

  • 8.1 Breast Cancer
    • 8.1.1 Overview
    • 8.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Prostate Cancer
    • 8.2.1 Overview
    • 8.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Lung Cancer
    • 8.3.1 Overview
    • 8.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Head and Neck Cancer
    • 8.4.1 Overview
    • 8.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Cervical Cancer
    • 8.5.1 Overview
    • 8.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

9. Radiation Oncology Market - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Radiation Oncology Market Overview
    • 9.1.2 North America: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.1.2.1 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.1.2.2 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.1.2.3 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.1.2.4 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.1.3 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.1.3.1 United States: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.3.1.1 United States: Radiation Oncology Market Breakdown, by Types
        • 9.1.3.1.2 United States: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.3.1.3 United States: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.3.1.4 United States: Radiation Oncology Market Breakdown, by Application
      • 9.1.3.2 Canada: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.3.2.1 Canada: Radiation Oncology Market Breakdown, by Types
        • 9.1.3.2.2 Canada: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.3.2.3 Canada: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.3.2.4 Canada: Radiation Oncology Market Breakdown, by Application
      • 9.1.3.3 Mexico: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.3.3.1 Mexico: Radiation Oncology Market Breakdown, by Types
        • 9.1.3.3.2 Mexico: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.3.3.3 Mexico: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.3.3.4 Mexico: Radiation Oncology Market Breakdown, by Application
  • 9.2 Europe
    • 9.2.1 Europe Radiation Oncology Market Overview
    • 9.2.2 Europe: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.2.2.1 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.2.2.2 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.2.2.3 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.2.2.4 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.2.3 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.2.3.1 Germany: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.1.1 Germany: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.1.2 Germany: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.1.3 Germany: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.1.4 Germany: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.2 United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.2.1 United Kingdom: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.2.2 United Kingdom: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.2.3 United Kingdom: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.2.4 United Kingdom: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.3 France: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.3.1 France: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.3.2 France: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.3.3 France: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.3.4 France: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.4 Spain: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.4.1 Spain: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.4.2 Spain: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.4.3 Spain: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.4.4 Spain: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.5 Italy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.5.1 Italy: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.5.2 Italy: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.5.3 Italy: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.5.4 Italy: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.6 Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.6.1 Rest of Europe: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.6.2 Rest of Europe: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.6.3 Rest of Europe: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.6.4 Rest of Europe: Radiation Oncology Market Breakdown, by Application
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific Radiation Oncology Market Overview
    • 9.3.2 Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.3.2.1 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.3.2.2 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.3.2.3 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.3.2.4 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.3.3 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.3.3.1 China: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.1.1 China: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.1.2 China: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.1.3 China: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.1.4 China: Radiation Oncology Market Breakdown, by Application
      • 9.3.3.2 Japan: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.2.1 Japan: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.2.2 Japan: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.2.3 Japan: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.2.4 Japan: Radiation Oncology Market Breakdown, by Application
      • 9.3.3.3 India: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.3.1 India: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.3.2 India: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.3.3 India: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.3.4 India: Radiation Oncology Market Breakdown, by Application
      • 9.3.3.4 Australia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.4.1 Australia: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.4.2 Australia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.4.3 Australia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.4.4 Australia: Radiation Oncology Market Breakdown, by Application
      • 9.3.3.5 South Korea: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.5.1 South Korea: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.5.2 South Korea: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.5.3 South Korea: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.5.4 South Korea: Radiation Oncology Market Breakdown, by Application
        • 9.3.3.5.5 Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.5.6 Rest of APAC: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.5.7 Rest of APAC: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.5.8 Rest of APAC: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.5.9 Rest of APAC: Radiation Oncology Market Breakdown, by Application
  • 9.4 Middle East and Africa
    • 9.4.1 Middle East and Africa Radiation Oncology Market Overview
    • 9.4.2 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.4.2.1 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.4.2.2 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.4.2.3 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.4.2.4 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.4.3 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.4.3.1 Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.1.1 Saudi Arabia: Radiation Oncology Market Breakdown, by Types
        • 9.4.3.1.2 Saudi Arabia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.4.3.1.3 Saudi Arabia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.4.3.1.4 Saudi Arabia: Radiation Oncology Market Breakdown, by Application
      • 9.4.3.2 South Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.2.1 South Africa: Radiation Oncology Market Breakdown, by Types
        • 9.4.3.2.2 South Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.4.3.2.3 South Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.4.3.2.4 South Africa: Radiation Oncology Market Breakdown, by Application
      • 9.4.3.3 United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.3.1 United Arab Emirates: Radiation Oncology Market Breakdown, by Types
        • 9.4.3.3.2 United Arab Emirates: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.4.3.3.3 United Arab Emirates: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.4.3.3.4 United Arab Emirates: Radiation Oncology Market Breakdown, by Application
      • 9.4.3.4 Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.4.1 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Types
        • 9.4.3.4.2 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.4.3.4.3 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.4.3.4.4 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Application
  • 9.5 South and Central America
    • 9.5.1 South and Central America Radiation Oncology Market Overview
    • 9.5.2 South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.5.2.1 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.5.2.2 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.5.2.3 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.5.2.4 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.5.3 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.1 Brazil: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.3.1.1 Brazil: Radiation Oncology Market Breakdown, by Types
        • 9.5.3.1.2 Brazil: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.5.3.1.3 Brazil: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.5.3.1.4 Brazil: Radiation Oncology Market Breakdown, by Application
      • 9.5.3.2 Argentina: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.3.2.1 Argentina: Radiation Oncology Market Breakdown, by Types
        • 9.5.3.2.2 Argentina: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.5.3.2.3 Argentina: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.5.3.2.4 Argentina: Radiation Oncology Market Breakdown, by Application
      • 9.5.3.3 Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.3.3.1 Rest of South and Central America: Radiation Oncology Market Breakdown, by Types
        • 9.5.3.3.2 Rest of South and Central America: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.5.3.3.3 Rest of South and Central America: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.5.3.3.4 Rest of South and Central America: Radiation Oncology Market Breakdown, by Application

10. Radiation Oncology Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Radiation Oncology Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Varian Medical Systems Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview (Siemens Healthineers AG)
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Elekta AB
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Accuray Incorporated
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 IBA Worldwide (Ion Beam Applications SA)
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Becton Dickinson and Co
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Perspective Therapeutics Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Nordion
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Mevion Medical Systems
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 NTP RADIOISOTOPES
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Mallinckrodt Plc
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Provision Healthcare
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments
  • 11.12 Panacea Medical Technologies Pvt. Ltd
    • 11.12.1 Key Facts
    • 11.12.2 Business Description
    • 11.12.3 Products and Services
    • 11.12.4 Financial Overview
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Developments
  • 11.13 Curium
    • 11.13.1 Key Facts
    • 11.13.2 Business Description
    • 11.13.3 Products and Services
    • 11.13.4 Financial Overview
    • 11.13.5 SWOT Analysis
    • 11.13.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms